Earlier this week, San Diego startup Gallant introduced $18 million in funding to deliver the primary FDA-approved ready-to-use stem cell remedy to veterinary medication. If it passes regulatory muster, it might create an...
Financial HighlightsRecord Revenue of $100 million, up from $40 million (+150%) in Q3 2021 and sequentially up 49% from Q2 of $67 millionGAAP Gross Margin of 9%, up from 8% in Q3 2021Net...
Science, research, and technological advancements have provided a better grasp of the precise processes that take place within the body as we age. The bodily processes that convert fuel (or food and air)...
Looking at STEM's weekly chart, the price seems to be struggling at $17, and I believe this is a strong resistance point to consider. However, looking at its simple moving averages indicator,...
